Bain Capital Life Sciences
Boston, Massachusettsbaincapitallifesciences.com
Overview
Bain Capital Life Sciences invests in biopharmaceutical, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that drive medical innovation to improve the lives of patients with unmet medical needs.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AdvanCell | Jul 2026 | Series D | Co-investor |
| CereVasc | Jun 2026 | Series C | Co-investor |
| Imperative Care | Mar 2026 | VC Round | Co-investor |
| Angitia Biopharmaceuticals | Feb 2026 | Series D | Co-investor |
| Syremis Therapeutics | Dec 2025 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
